We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Celltrion Group has completed a neutralisation test and identified the antibody candidates that showed the most promise for neutralising the novel coronavirus, SARS-CoV-2, which causes Covid-19.